Our study found that the increased expression of AKR1B10 may promote the increase of the expression level of CTLA-4, which may lead to the enhancement of the negative regulation of the immune system and the inhibition of the activation and proliferation of T cells, thereby reducing the immune response ability of the body, and then affecting the development and deterioration of liver cancer. This evidence concerns the gene AKR1B10 and liver cancer.